Poging GOUD - Vrij

Tesla's autopilot verdict reveals a glaring flaw

Financial Express Chandigarh

|

August 06, 2025

A Miami jury just sided with the humans. The $243 million of damages levied against Tesla Inc. over a fatal Autopilot crash in 2019 represent a black eye for a company that has often successfully blamed human error in prior accidents. It will hopefully be more than that: an impetus to fix a glaring flaw in the drive for ever more automated vehicles.

- Liam Denning Bloomberg

An unusual aspect of this case, Benavides vs Tesla, was that the driver admitted he was at fault, having sped through a stop sign while searching for a dropped cellphone, killing Naibel Benavides Leon and seriously injuring her boyfriend as they stood next to their parked SUV. The jury did indeed blame the distracted driver but assigned him only two-thirds of that blame. The rest was laid on Tesla. Not only must it pay its share of compensatory damages to the victims, amounting to about $43 million, but also $200 million of punitive damages.

During the trial, the driver said that although he knew he was responsible for operating his Model S, he had expected his Autopilot system to help if he made an error. Autopilot combines autosteer and dynamic cruise control and is designed to relieve some of the driver's workload rather than displace it altogether by keeping the vehicle centered in its lane and maintaining a safe distance from vehicles in front when traveling. Ask yourself if that is what springs to mind when you hear the word "autopilot" as opposed to a general sense that such a machine pilots itself. The judge raised that confusion when allowing the case to proceed to trial.

MEER VERHALEN VAN Financial Express Chandigarh

Financial Express Chandigarh

'Global norms ensure domestic crypto investor safety'

The long-term goal of Binance Holdings, the world’s largest crypto exchange in terms of volumes, is to become a collaborative partner for India’s blockchain and digital asset ecosystem, SB Seker, head of the Asia-Pacific region, an interview.

time to read

2 mins

December 13, 2025

Financial Express Chandigarh

Govt speeds up visa for Chinese professionals

• Processing time less than 1 month now; China sees ‘positive action’

time to read

1 min

December 13, 2025

Financial Express Chandigarh

Rupee hits fresh closing low, drift may continue

It touched 90.56 against the dollar intra day

time to read

1 mins

December 13, 2025

Financial Express Chandigarh

Silver hits ₹2 lakh in futures trade

SILVER PRICES RALLIED on Friday to breach the record ₹2 lakh per kg mark in futures trade for the first time, riding on strong investor demand and positive global trends.

time to read

1 min

December 13, 2025

Financial Express Chandigarh

INITIATIVE TO COVER CRITICAL MINERALS, CHIPS India left out of US-led supply chain coalition

A NEW US-LED strategic initiative, Pax Silica, which aims to build a secure supply chain ranging from critical minerals and energy inputs to advanced manufacturing and semiconductors, does not include India.

time to read

2 mins

December 13, 2025

Financial Express Chandigarh

Vinesh returns to the mat, eyes medal at 2028 Games

STAR WRESTLER VINESH PHOGAT on Friday announced that she would be coming out of retirement to take another shot at an elusive Olympic medal at the 2028 Los Angeles Games as the “the fire never left” her and was merely buried under “exhaustion and noise”.

time to read

1 mins

December 13, 2025

Financial Express Chandigarh

Airline moves Delhi HC for ₹900-crore IGST refund

Airline moves Delhi HC for ₹900-crore IGST refund

time to read

1 min

December 13, 2025

Financial Express Chandigarh

Ozempic adds to growing...

NOVO NORDISKCLAIMS it also reduces cardiovascular and renal risks.

time to read

1 min

December 13, 2025

Financial Express Chandigarh

SBI reduces lending rates after RBI rate cut

STATE BANK OF India (SBI) on Friday revised its lending rates following the Reserve Bank of India’s latest 25-bps reduction in the repo rate.

time to read

1 min

December 13, 2025

Financial Express Chandigarh

Ozempic adds to India's growing appetite for anti-obesity drugs

Novo Nordisk launches medicine at starting price of ₹2,200 a week

time to read

1 min

December 13, 2025

Listen

Translate

Share

-
+

Change font size